- Report
- November 2023
- 400 Pages
Global
From €3862EUR$3,995USD£3,319GBP
- Report
- November 2023
- 300 Pages
Global
From €3862EUR$3,995USD£3,319GBP
The Vaccine Partnering market is a subset of the Vaccines industry, which focuses on the development and commercialization of vaccines. Vaccine partnering is the process of two or more organizations coming together to collaborate on the development, manufacturing, and distribution of vaccines. This type of collaboration is beneficial for both parties, as it allows them to share resources, expertise, and risk. Vaccine partnering can take many forms, such as joint ventures, licensing agreements, and research collaborations.
The Vaccine Partnering market is highly competitive, with many organizations vying for the best partnerships. Companies in the market include Merck, Pfizer, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. Other players include CSL, Emergent BioSolutions, and Novavax. Show Less Read more